Diabetic Peripheral Neuropathy (DPN)

DBCOND0049986Digestive System DiseasesEndocrine System Diseases

Diabetic Peripheral Neuropathy (DPN) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Diabetic Peripheral Neuropathy · Peripheral Diabetic Neuropathy · Diabetic Neuropathy Peripheral
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT190353001MedDRA10012680UMLSC0011882

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
83Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Diabetic Peripheral Neuropathy (DPN) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In